ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,460.48
-0.41%
US Tech 100
19,181.60
-0.43%
Dow Jones
39,118.86
-0.12%
Brent Oil
84.85
0.00%
Bitcoin
61,503.72
1.01%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
09/26/20222:48AMDow Jones NewsGSK PLC Names Julie Brown as New CFO; Iain Mackay to Retire in MayNYSE:GSKGSK plc
09/26/20222:16AMDow Jones NewsGSK to Appoint Julie Brown as Next Finance Chief, Sky ReportsNYSE:GSKGSK plc
09/23/202212:25PMTipRanksGSK Pharma call volume above normal and directionally bullishNYSE:GSKGSK plc
09/22/20226:54PMDow Jones NewsADRs End Mostly Lower; Compagnie de Saint-Gobain Trades ActivelyNYSE:GSKGSK plc
09/22/202210:20AMAllPennyStocks.comMicro Cap Up Over +100% In PremarketNYSE:GSKGSK plc
09/22/20226:30AMDow Jones NewsSpero Therapeutics Shares Take Flight Premarket on GSK PactNYSE:GSKGSK plc
09/22/20222:50AMDow Jones NewsGSK Secures Urinary Tract Infections Treatment License With Spero TherapeuticsNYSE:GSKGSK plc
09/22/20222:00AMGlobeNewswire Inc.GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBrNYSE:GSKGSK plc
09/21/20226:57AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/19/20226:47AMDow Jones NewsTheravance to Buy GSK's Stake as Part of $250 Million BuybackNYSE:GSKGSK plc
09/08/20228:38AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/07/202212:59PMDow Jones NewsSpringWorks Therapeutics Shares Rise 8% After Expanding GSK AgreementNYSE:GSKGSK plc
09/07/202210:39AMDow Jones NewsSpringWorks Therapeutics in Licensing, Collaboration Deal With GSKNYSE:GSKGSK plc
09/07/20229:55AMGlobeNewswire Inc.SpringWorks Announces Expansion of Global, Non-Exclusive Collaboration with GSK for Nirogacestat in Combination with Blenrep in Patients with Multiple MyelomaNYSE:GSKGSK plc
09/06/202210:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
09/01/20228:53AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/24/20226:48AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/22/202212:51PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/17/20226:11AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/17/20226:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/17/20222:46AMDow Jones NewsGSK Says FDA Accepts Momelotinib's New Drug ApplicationNYSE:GSKGSK plc
08/17/20222:20AMDow Jones NewsGSK Says Plaintiff to Drop Zantac CaseNYSE:GSKGSK plc
08/16/20226:18AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/12/20224:48AMDow Jones NewsGSK, Sanofi, Haleon Shares Recover Some Recent Losses After Zantac Drug ResponsesNYSE:GSKGSK plc
08/12/20223:30AMDow Jones NewsHaleon Says It Hasn't Been Notified About Litigation on Zantac Drug -- UpdateNYSE:GSKGSK plc
08/11/20227:28AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/10/20221:42PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
08/08/20224:02PMGlobeNewswire Inc.Mersana Therapeutics Announces Option Agreement with GSK for the Co-Development and Commercialization of XMT-2056, an Immunosynthen ADC Targeting HER2NYSE:GSKGSK plc
08/08/202212:29PMBusiness WireADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwideNYSE:GSKGSK plc
08/08/202210:42AMBusiness WireGSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwideNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

BIT
Q00283
Leonteq Securities
BIT
UI319C
Unicredit Bank
BIT
OSA
OSAI Automation System
AQSE
CAR.GB
Carclo
BIT
O8JPF4
Morgan Stanley BV
BIT
P1VMC8
NLBNPIT1VMC8 20991231 15...
BIT
P1YKP8
NLBNPIT1YKP8 20991231 30...
BIT
P1ZMR7
NLBNPIT1ZMR7 20241220 40
BIT
F16417
Vontobel Financial Produ...
BIT
P1YQU5
NLBNPIT1YQU5 20991231 2....
BIT
P1Z0V8
NLBNPIT1Z0V8 20991231 34...
BIT
I05059
Banca IMI
EU
CDCDC
Caisse Depots Et Consign...
BIT
L82999
Credit Agricole Corporat...
BIT
3LNI
GraniteShares 3x Long NI...
BIT
UV8CST
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved